Clinical Trials Browser

INDUSTRY × Observational × Observation × Clear all

NCT05257551 2026-04-02

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

Neoplasms, Small Cell Lung Carcinoma

NCT05236114 2026-02-05

GEMINI-NSCLC: NSCLC Biomarker Study

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT06887348 2026-01-12

RPx

DermatologicGastrointestinal

Carcinoma, Hepatocellular, Melanoma

NCT04770571 2025-12-22

Posterior Cervical Fixation Study

Enrolling by invitation

Klippel-Feil Syndrome, Radiculopathy, Thoracic Injuries, Trauma, Nervous System, Intervertebral Disc Degeneration

NCT05323747 2025-09-16

BP-008

Prostatic Neoplasms

NCT05354427 2025-09-16

CLP-10095

Prostatic Neoplasms

NCT06192004 2025-06-03

LOOP

Carcinoma, Non-Small-Cell Lung, Pneumonia, Lung Diseases, Interstitial

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Active not recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05234177 2025-05-06

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT04528407 2025-02-13

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

Papillomavirus Infections

NCT06008353 2024-12-19

EDUR-BRA

Active not recruiting

Small Cell Lung Carcinoma

NCT05592483 2024-11-07

DB RESPOND

Breast Neoplasms

NCT05775549 2024-09-20

FLAME

Advanced Ovarian Cancer

NCT06126003 2024-08-02

Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

Breast Neoplasms

NCT04566432 2024-07-18

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04857619 2024-07-11

Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer

Breast Neoplasms

NCT04060290 2024-02-28

Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors

Neoplasms

NCT05292443 2024-02-23

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT02733601 2023-04-03

BreCaReAl

Breast Neoplasms, Neoplasms

NCT04807595 2023-03-06

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

Breast Neoplasms

NCT05032352 2022-11-14

PADMA

Carcinoma, Non-Small-Cell Lung

NCT05423431 2022-06-24

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Prostatic Neoplasms

NCT00754000 2012-04-30

AIM

Prostatic Neoplasms